Literature DB >> 24989077

Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents.

Oyekoya T Ayonrinde1, John K Olynyk, Julie A Marsh, Lawrence J Beilin, Trevor A Mori, Wendy H Oddy, Leon A Adams.   

Abstract

BACKGROUND AND AIM: Nonalcoholic fatty liver disease (NAFLD) and its metabolic risk factors are recognized during childhood and adolescence. Identification of adolescents at risk of NAFLD from childhood anthropometry may expose opportunities to influence the hepatic and metabolic destinies of individuals. We sought associations between NAFLD diagnosed during adolescence and earlier life trajectories of anthropometry, in a population-based cohort of predominantly Caucasian adolescents.
METHODS: Assessment for NAFLD, using questionnaires and liver ultrasound, was performed on 1170 adolescents, aged 17 years, from the population-based Raine cohort. We sought associations between NAFLD in adolescents and serial anthropometric measurements recorded from birth, childhood, and adolescence.
RESULTS: NAFLD was diagnosed in 15.2% of adolescents. Birth anthropometry, including birth weight, skinfold thickness, and ponderal index, was not associated with NAFLD. However, adiposity differences between 17-year-old adolescents with NAFLD and those without NAFLD were apparent from age 3 years. Greater adiposity trajectories for weight, body mass index, skinfold thickness, mid-arm circumference, and chest circumference from age 3 years onwards, particularly in males, were associated with the diagnosis of NAFLD and severity of hepatic steatosis at age 17 years (P < 0.05). The strength of the associations increased with age after 3 years for each adiposity measure (all P < 0.001).
CONCLUSIONS: Trajectories of childhood adiposity are associated with NAFLD. Adiposity attained by 3 years of age and older, but not at birth, was associated with the diagnosis and severity of hepatic steatosis in late adolescence. Exploration of clinically relevant risk factors and preventative measures for NAFLD should begin during childhood.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  anthropometry; body mass index; cohort study; nonalcoholic fatty liver disease; skinfold thickness

Mesh:

Year:  2015        PMID: 24989077     DOI: 10.1111/jgh.12666

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat.

Authors:  R Malpique; J Bassols; A López-Bermejo; M Diaz; F Villarroya; J Pavia; A Congo; F de Zegher; L Ibáñez
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

2.  Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.

Authors:  Yinkun Yan; Dongqing Hou; Xiaoyuan Zhao; Junting Liu; Hong Cheng; Youfa Wang; Jie Mi
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

3.  Body composition trajectories from birth to 5 years and hepatic fat in early childhood.

Authors:  Catherine C Cohen; Kylie K Harrall; Stephanie P Gilley; Wei Perng; Katherine A Sauder; Ann Scherzinger; Kartik Shankar; Shikha S Sundaram; Deborah H Glueck; Dana Dabelea
Journal:  Am J Clin Nutr       Date:  2022-10-06       Impact factor: 8.472

4.  Subcutaneous fat mass in infancy and abdominal, pericardial and liver fat assessed by Magnetic Resonance Imaging at the age of 10 years.

Authors:  Bernadeta Patro Golab; Ellis Voerman; Aad van der Lugt; Susana Santos; Vincent W V Jaddoe
Journal:  Int J Obes (Lond)       Date:  2018-12-19       Impact factor: 5.095

5.  Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register.

Authors:  Esther Zimmermann; Michael Gamborg; Claus Holst; Jennifer L Baker; Thorkild I A Sørensen; Tina L Berentzen
Journal:  BMJ Open       Date:  2015-05-03       Impact factor: 2.692

Review 6.  Sirtuins and nonalcoholic fatty liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

7.  Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease.

Authors:  Joy Simpson; Andrew D Smith; Abigail Fraser; Naveed Sattar; Mark Callaway; Robert S Lindsay; Debbie A Lawlor; Scott M Nelson
Journal:  J Clin Endocrinol Metab       Date:  2016-09-20       Impact factor: 5.958

8.  The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice.

Authors:  Fahrettin Haczeyni; Hans Wang; Vanessa Barn; Auvro R Mridha; Matthew M Yeh; W Geoffrey Haigh; George N Ioannou; Yun-Jung Choi; Charles A McWherter; Narcissus C-H Teoh; Geoffrey C Farrell
Journal:  Hepatol Commun       Date:  2017-07-31

9.  Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.

Authors:  Shaman Rajindrajith; Arunasalam Pathmeswaran; Chamilka Jayasinghe; Dulani Kottahachchi; Anuradhani Kasturiratne; Shamila T de Silva; Madunil A Niriella; Anuradha S Dassanayake; Arjuna P de Silva; H Janaka de Silva
Journal:  BMC Gastroenterol       Date:  2017-11-29       Impact factor: 3.067

Review 10.  A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.

Authors:  Jonathan L Temple; Paul Cordero; Jiawei Li; Vi Nguyen; Jude A Oben
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.